WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bicara Therapeutics earnings were -$157.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest BCAX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$56.2M, up 50.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BCAX reported annual earnings of -$138.0M, with 102.9% growth. The next BCAX earnings date is Aug 11, 2026.

BCAX earnings history

Current Revenue
$0.0
Current Earnings
-$157.3M
Current Profit Margin
0%

BCAX Return on Equity

Current Company
-35.9%
Current Industry
-141.9%
Current Market
13.5%
BCAX's Return on Equity (-35.9%)... subscribe to Premium to read more.
High Return on Equity Performance

BCAX Return on Assets

Current Company
-33.8%
Current Industry
-13.7%
BCAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BCAX announces earnings.

BCAX Return on Capital Employed

Current Company
-30.55%
Current Industry
-9.6%

BCAX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BCAX-$155.96M-$157.32MN/A-$2.78
DMRA-$234.91M-$235.09M-63.52%$5.28
OCUL-$274.25M-$290.50MN/A-$1.44
AGIO-$394.04M-$411.29MN/A-$7.01
LKFTN/A$575.03MN/AN/A
View Top Biotech Stocks

BCAX earnings dates

Next earnings date
Aug 11, 2026

Bicara Therapeutics Earnings Reports & History FAQ

What were Bicara Therapeutics's earnings last quarter?

On BCAX's earnings call on May 19, 2026, Bicara Therapeutics (NASDAQ: BCAX) reported Q1 2026 earnings per share (EPS) of -$0.93, up 36.76% year over year. Total BCAX earnings for the quarter were -$56.21 million. In the same quarter last year, Bicara Therapeutics's earnings per share (EPS) was -$0.68.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.

When does Bicara Therapeutics report earnings?

The next BCAX earnings call is Aug 11, 2026. Add BCAX to your watchlist to be reminded of Bicara Therapeutics's next earnings date.

Is Bicara Therapeutics profitable or losing money?

As of the last Bicara Therapeutics earnings report, Bicara Therapeutics is currently losing money. Bicara Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$157.32 million, a 70.38% increase year over year.

What was BCAX's earnings growth in the past year?

As of Bicara Therapeutics's earnings date in May 19, 2026, Bicara Therapeutics's earnings has grown year over year. BCAX earnings in the past year totalled -$157.32 million.

What are Bicara Therapeutics's earnings expectations?

The current EPS estimate for Bicara Therapeutics's earnings report in Aug 11, 2026 is -$0.77.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.